Enhancer of zeste homolog 2 (EZH2) promotes expansion of breast tumor initiation cells through activation of Notch1-jagged signaling

被引：0
|
作者：
Gonzalez, Maria E. [1 ]
Li, Xin [1 ]
Kruger, Heather [1 ]
Toy, Kathy [1 ]
Kleer, Celina G. [1 ]
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-3345
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3345
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Positive Expression of Enhancer of Zeste Homolog 2 (EZH2) Predicts Shorter Overall Survival in Patients with Inflammatory Breast Cancer
    Gong, Y.
    Huo, L.
    Sneige, N.
    Cristofanilli, M.
    MODERN PATHOLOGY, 2010, 23 : 47A - 48A
  • [22] Positive Expression of Enhancer of Zeste Homolog 2 (EZH2) Predicts Shorter Overall Survival in Patients with Inflammatory Breast Cancer
    Gong, Y.
    Huo, L.
    Sneige, N.
    Cristofanilli, M.
    LABORATORY INVESTIGATION, 2010, 90 : 47A - 48A
  • [23] Epigenetic regulation of enhancer of zeste homolog 2 (EZH2) -Yin Yang 1 (YY1) axis in cancer
    Chandnani, Nikhil
    Gupta, Ishika
    Thakkar, Vidhi
    Sarkar, Koustav
    PATHOLOGY RESEARCH AND PRACTICE, 2023, 251
  • [24] Anti-cancer Effects of Curcumin on Myelodysplastic Syndrome through the Inhibition of Enhancer of Zeste Homolog-2 (EZH2)
    Ma, Ling
    Zhang, Xia
    Wang, Zhiqiong
    Huang, Lifang
    Meng, Fankai
    Hu, Lihua
    Chen, Yan
    Wei, Jia
    CURRENT CANCER DRUG TARGETS, 2019, 19 (09) : 729 - 741
  • [25] The enhancer of zeste homolog 2 (EZH2), a potential therapeutic target, is regulated by miR-101 in renal cancer cells
    Sakurai, Toshihiko
    Bilim, Vladimir N.
    Ugolkov, Andrey V.
    Yuuki, Kaori
    Tsukigi, Masaaki
    Motoyama, Teiichi
    Tomita, Yoshihiko
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 422 (04) : 607 - 614
  • [26] ENHANCER OF ZESTE HOMOLOG 2 (EZH2) EXPRESSION AND ACTIVATION IN IN VIVO AND IN VITRO NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
    Gnani, D.
    Vella, S.
    Crudele, A.
    Ceccarelli, S.
    De Stefanis, C.
    Gaspari, S.
    Nobili, V.
    Locatelli, F.
    Marquez, V. E.
    Rota, R.
    Alisi, A.
    DIGESTIVE AND LIVER DISEASE, 2014, 46 : E28 - E28
  • [27] Ezh2 promotes mammary tumor initiation through epigenetic regulation of the Wnt and mTORC1 signaling pathways
    Liu, Linshan
    Xiao, Bin
    Hirukawa, Alison
    Smith, Harvey W.
    Zuo, Dongmei
    Sanguin-Gendreau, Virginie
    McCaffrey, Luke
    Nam, Alice Jisoo
    Muller, William J.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2023, 120 (33)
  • [28] MicroRNA-638 induces apoptosis and autophagy in human liver cancer cells by targeting enhancer of zeste homolog 2 (EZH2)
    Zhang, Hongyu
    Liang, Hongxia
    Wu, Shuhuan
    Zhang, Yingying
    Yu, Zujiang
    ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2021, 82
  • [29] Inhibition of Enhancer of zeste homolog 2 (EZH2) induces natural killer cell-mediated eradication of hepatocellular carcinoma cells
    Bugide, Suresh
    Green, Michael R.
    Wajapeyee, Narendra
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (15) : E3509 - E3518
  • [30] Overexpression of enhancer of zeste homolog 2 (EZH2) and focal adhesion kinase (FAK) is associated with cancer metastasis and poor prognosis in breast cancer
    Guo, Yawen
    Maimaiti, Yusufu
    Yu, Pan
    Liu, Zeming
    Chen, Chen
    Zhang, Yunke
    Yin, Xingjie
    Wang, Shan
    Xiu, Nie
    Bangxing, Huang
    Liu, Chunping
    Huang, Tao
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (02): : 2672 - 2683
12345